U.S. Markets open in 7 hrs 57 mins

Zacks Value Trader Highlights: Sinopec, Health Insurance Innovations, Navient, Ford and Delta

Zacks Equity Research

For Immediate Release

Chicago, IL – July 19, 2019 – Zacks Value Trader is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:

Cheapest Zacks Rank #1 Stocks Right Now

Welcome to Episode #150 of the Value Investor Podcast

Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.

Zacks has a great stock ranking system called the Zacks Rank.

The top ranking is the Zacks #1 (Strong Buy) stocks. Out of the over 4,000 stocks that have a Zacks Rank, today there are just 224 stocks that are the top ranking.

Usually a stock that has a Zacks Rank #1 has rising earnings estimates.

But value investors can also combine it with value fundamentals, such as the price-to-earning ratio and the price-to-sales ratio to come up with the cheapest top Zacks Ranked stocks.

Of course, the Rank is only looking at the earnings estimates. Investors should dig deeper to find out the fundamentals of any company.

But this basic screen can provide ideas.

Screening for Top Zacks Ranked Stocks

Using the Zacks #1 Rank, plus a forward P/E under 10 and a P/S ratio under 1.0, returns just 13 stocks out of the universe of 224 #1 ranked stocks.

These are some of the cheapest from that screen.

5 Cheap #1 Rank Stocks

1.       Sinopec SHI is a Chinese petrochemical company. It is the cheapest of the #1 Rank stocks. Earnings are expected to rise 8.8% in 2019 and one estimate was raised in the last week. You won’t believe it’s P/E.

2.       Health Insurance Innovations HIIQ is a small-cap Florida insurance company. Year-to-date the shares have fallen 19.4% but earnings are expected to grow 50.7% this year. 4 estimates have been revised higher in the last month. It has a forward P/E of just 5.5. Healthcare insurance stocks are out of favor but could this be a buying opportunity?

3.       Navient Corp. NAVI provides student loans to 12 million customers. The shares have rallied in 2019, gaining 54% but are still cheap with a forward P/E of just 0.6. Investors also get rewarded with a dividend, currently yielding 4.7%.

4.       Ford F has been cheap for some time even though the shares have rallied 35% in 2019. It still sports a single digit P/E. Investors also get a dividend, which is yielding 5.7%. One estimate has been revised higher for 2019. Ford is expected to grow earnings 6.9% this year.

5.       Delta DAL has already reported earnings but the analysts liked what they hear because 5 estimates have been revised higher in just the last week. Earnings are expected to grow 25% in 2019. Shares are still cheap with a forward P/E of just 9.

What else should you know about cheap stocks?

Tune into this week’s podcast to find out.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/performance

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.